Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure ...

We're getting a lot of interest lately," this company's CEO said after a deal that saved the company's Covid vaccine push.

Vaccine makers saw their shares fall Monday on the New York Stock Exchange following the leak of a document attributed to a ...

WASHINGTON, DC – Dr Vinay Prasad, the Food and Drug Administration’s vaccine chief, ignited a political and scientific ...

A top FDA official has proposed broad changes to the review and approval process for vaccines, citing a new internal review linking the deaths of 10 children to COVID-19 vaccines. In an internal memo ...

Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...

The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.

Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official [claimed the shots]( ...